Trailing Twelve Months Revenue Growth: Coherus Biosciences (CHRS)

Public company logo of coherus.com (CHRS)

Coherus Biosciences is implementing environmental standards to minimize the impact of chemical synthesis and reduce its carbon footprint. The year-over-year relative revenue growth rate (12 months) confirms the business dynamics, where the current parameter equals -35.30. The company relies on production outsourcing via CMOs, while the expansion of biosimilars and AI solutions strengthens its position on insurance formularies.

Coherus Biosciences (CHRS): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Coherus Biosciences - analytical breakdowns and key metrics (CHRS)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:Coherus BioSciences Inc.
Brand item of Coherus BioSciences, Inc

The commercialization of Coherus Biosciences (CHRS) biosimilars in the US is protected by the humanitarian status of medicine, which minimizes geopolitical risks to operational activities. The annual revenue growth rate over the trailing four quarters measures the dynamics of sales expansion, allowing investors to identify early signs of revenue contraction and assess business resilience to market shocks via TTM trend analysis prior to the publication of official financial statements.

Who Coherus Biosciences competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CRBP (Corbus Pharmaceuticals Holdings)|Cardiff Oncology - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)